(CTN News) – The US Food and Drug Administration authorised Xolair, a medicine that reduces the intensity of allergy reactions in those who are allergic to various foods. Xolair, developed and co-marketed by Genentech and Novartis in the United States, was first licenced in 2003 for the treatment of moderate to severe persistent allergic asthma […]

Go to Source
Author: Arsi Mughal